| | LOC129390903, RAD51C (N203D) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC129390903, RAD51C (R212C) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (R212H) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (E218fs) | Microsatellite (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (L225P) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC129390903, RAD51C (E232D) | Single nucleotide variant (missense variant +1 more) | RAD51C-related disorder +4 more | |
| | LOC129390903, RAD51C (S234*) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (K235N) | Single nucleotide variant (missense variant +1 more) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +3 more | |